top of page

2023

Publications 2023

  • Abozaid YJ, Ayada I, van Kleef LA, Vallerga CL, Pan Q, Brouwer WP, Ikram MA, Van Meurs J, de Knegt RJ, Ghanbari M. Plasma proteomic signature of fatty liver disease: The Rotterdam Study. Hepatology. 2023;78(1):284-94.

  • Arkenbosch JHC, Becker MAJ, Buskens CJ, Witjes C, de Vries AC, van der Woude CJ, Fuhler G, Wildenberg ME, van Ruler O. Platelet-Rich stroma from Crohn's disease patients for treatment of perianal fistula shows a higher myeloid cell profile compared to non-IBD controls. Stem Cell Res. 2023;67:103039.

  • Arkenbosch JHC, Beelen EMJ, Dijkstra G, Romberg-Camps M, Duijvestein M, Hoentjen F, van der Marel S, Maljaars PWJ, Jansen S, de Boer NKH, West RL, Horjus CS, Stassen LPS, van Schaik FDM, van Ruler O, Jharap BJH, Visschedijk M, Janssen A, Erler NS, Doukas M, Ooms A, Kats-Ugurlu G, van der Woude CJ, de Vries AC. Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk Stratification. J Crohns Colitis. 2023;17(2):221-30.

  • Arkenbosch JHC, van Ruler O, Dwarkasing RS, Fuhler GM, Schouten WR, van Oud-Alblas MB, de Graaf EJR, de Vries AC, van der Woude CJ. Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn's disease: A pilot study. Aliment Pharmacol Ther. 2023;57(7):783-91.

  • Ayada I, van Kleef LA, Zhang H, Liu K, Li P, Abozaid YJ, Lavrijsen M, Janssen HLA, van der Laan LJW, Ghanbari M, Peppelenbosch MP, Zheng MH, de Knegt RJ, Pan Q. Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study. EBioMedicine. 2023;87:104392.

  • Ayoub A, Anugwom CM, Prieto J, Balderramo D, Ferrer JD, Mattos AZ, Arrese M, Carrera E, Groothuismink ZMA, Oliveira J, Boonstra A, Debes JD. Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans. Cancers (Basel). 2023;15(18).

  • Bak MTJ, Albeniz E, East JE, Coelho-Prabhu N, Suzuki N, Saito Y, Matsumoto T, Banerjee R, Kaminski MF, Kiesslich R, Coron E, de Vries AC, van der Woude CJ, Bisschops R, Hart AL, Itzkowitz SH, Pioche M, Moons LMG, Oldenburg B. Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study. Gastrointest Endosc. 2023;97(4):767-79 e6.

  • Bak MTJ, van Ruler O, Stassen L, Ruiterkamp M, Arkenbosch JHC, Dijkstra G, Campmans-Kuijpers MJE, van Meeteren NLU, Bongers BC, Romberg-Camps M, van der Marel S, Hoentjen F, van Dongen KW, West R, van der Woude J, de Vries AC, Dutch Initiative C, Colitis, Dutch Initiative on C, Colitis S. Preoperative screening and prehabilitation strategies prior to ileocolic resection in patients with Crohn's disease are not incorporated in routine care. Int J Colorectal Dis. 2023;38(1):254.

  • Beelen EMJ, Arkenbosch JHC, Erler NS, Sleutjes JAM, Hoentjen F, Bodelier AGL, Dijkstra G, Romberg-Camps M, de Boer NK, Stassen LPS, van der Meulen AE, West R, van Ruler O, van der Woude CJ, de Vries AC. Impact of timing of primary ileocecal resection on prognosis in patients with Crohn's disease. BJS Open. 2023;7(5).

  • Beudeker BJB, Fu S, Balderramo D, Mattos AZ, Carrera E, Diaz J, Prieto J, Banales J, Vogel A, Arrese M, Oliveira J, Groothuismink ZMA, van Oord G, Hansen BE, de Man RA, Debes JD, Boonstra A. Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe. Hepatol Commun. 2023;7(10).

  • Boxhoorn L, Verdonk RC, Besselink MG, Boermeester M, Bollen TL, Bouwense SA, Cappendijk VC, Curvers WL, Dejong CH, van Dijk SM, van Dullemen HM, van Eijck CH, van Geenen EJ, Hadithi M, Hazen WL, Honkoop P, van Hooft JE, Jacobs MA, Kievits JE, Kop MP, Kouw E, Kuiken SD, Ledeboer M, Nieuwenhuijs VB, Perk LE, Poley JW, Quispel R, de Ridder RJ, van Santvoort HC, Sperna Weiland CJ, Stommel MW, Timmerhuis HC, Witteman BJ, Umans DS, Venneman NG, Vleggaar FP, van Wanrooij RL, Bruno MJ, Fockens P, Voermans RP, Dutch Pancreatitis Study G. Comparison of lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis. Gut. 2023;72(1):66-72.

  • Breekveldt ECH, Toes-Zoutendijk E, de Jonge L, Spaander MCW, Dekker E, van Kemenade FJ, van Vuuren AJ, Ramakers CRB, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT). BMC Gastroenterol. 2023;23(1):45.

  • Breekveldt ECH, Toes-Zoutendijk E, Spaander MCW, van de Schootbrugge-Vandermeer HJ, van Vuuren AJ, van Kemenade FJ, Ramakers CRB, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands. Eur J Cancer. 2023;178:60-7.

  • Breekveldt ECH, Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, de Jonge L, Kooyker AI, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Ramakers C, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program. Int J Cancer. 2023;152(8):1536-46.

  • Bretthauer M, Mori Y, Zessner-Spitzenberg J, Kaminski MF, Siersema PD, Ponchon T, Messmann H, Gralnek IM, Bisschops R, Hassan C. Gastrointestinal endoscopy devices and the European Union Medical Device Regulation: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2023;55(6):578-81.

  • Brakenhoff SM, de Knegt RJ, van Campenhout MJH, van der Eijk AA, Brouwer WP, van Bommel F, Boonstra A, Hansen BE, Berg T, Janssen HLA, de Man RA, Sonneveld MJ. End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients. J Microbiol Immunol Infect. 2023;56(1):31-9.

  • Brakenhoff SM, Hoekstra R, Honkoop P, Roomer R, den Hollander JG, Bezemer G, de Knegt RJ, Sonneveld MJ, de Man RA. Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country. Eur J Intern Med. 2023;108:68-73.

  • Bruno MJ. Endoscopy in Gallstone Pancreatitis. Gastrointest Endosc Clin N Am. 2023;33(4):701-7.

  • Bruno MJ, Beyna T, Carr-Locke D, Chahal P, Costamagna G, Devereaux B, Giovannini M, Goenka MK, Khor C, Lau J, May G, Muthusamy VR, Patel S, Petersen BT, Pleskow DK, Raijman I, Reddy DN, Repici A, Ross AS, Sejpal DV, Sherman S, Siddiqui UD, Ziady C, Peetermans JA, Rousseau MJ, Slivka A, Group ES-uDS. Global prospective case series of ERCPs using a single-use duodenoscope. Endoscopy. 2023;55(12):1103-14.

  • Chan HLY, Buti M, Lim YS, Agarwal K, Marcellin P, Brunetto M, Chuang WL, Janssen HLA, Fung S, Izumi N, Abdurakhmanov D, Jablkowski M, Celen MK, Ma X, Caruntu F, Flaherty JF, Abramov F, Wang H, Camus G, Osinusi A, Pan CQ, Shalimar D, Seto WK, Gane E. Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety. Am J Gastroenterol. 2023;119(3):486-96.

  • Choi HSJ, Hirode G, Chen CH, Su TH, Seto WK, Van Hees S, Papatheodoridi M, Lens S, Wong GLH, Brakenhoff SM, Chien RN, Feld JJ, Sonneveld MJ, Chan HLY, Forns X, Papatheodoridis GV, Vanwolleghem T, Yuen MF, Hsu YC, Kao JH, Cornberg M, Hansen BE, Jeng WJ, Janssen HLA, group R-Bs. Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2023;21(6):1513-22 e4.

  • Dang H, Dekkers N, Steyerberg EW, Baldaque-Silva F, Omae M, Haasnoot KJC, van Tilburg L, Nobbenhuis K, van der Kraan J, Langers AMJ, van Hooft JE, de Graaf W, Koch AD, Didden P, Moons LMG, Hardwick JCH, Boonstra JJ. Predicting procedure duration of colorectal endoscopic submucosal dissection at Western endoscopy centers. Endosc Int Open. 2023;11(8):E724-E32.

  • Dang H, Dekkers N, Steyerberg EW, Baldaque-Silva F, Omae M, Haasnoot KJC, van Tilburg L, Nobbenhuis K, van der Kraan J, Langers AMJ, van Hooft JE, de Graaf W, Koch AD, Didden P, Moons LMG, Hardwick JCH, Boonstra JJ. Correction: Predicting procedure duration of colorectal endoscopic submucosal dissection at Western endoscopy centers. Endosc Int Open. 2023;11(8):C5.

  • de Jong DM, den Hoed CM, Willemssen F, Thomeer MGJ, Bruno MJ, Koerkamp BG, de Jonge J, Alwayn IPJ, van Hooft JE, Hoogwater F, van der Heide F, Inderson A, van Vilsteren FGI, van Driel L. Impact of EUS in liver transplantation workup for patients with unresectable perihilar cholangiocarcinoma. Gastrointest Endosc. 2023.

  • de Veer RC, van Hooff MC, Corpechot C, Thorburn D, Invernizzi P, Lammers WJ, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Pares A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Goet JC, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Hansen BE, Harms MH, van der Meer AJ, Global PBCSG. Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis. Am J Gastroenterol. 2023;118(7):1196-203.

  • de Veer RC, van Hooff MC, da Silva G, Harms MH, Metselaar HJ, Willemse J, Utomo E, van der Meer AJ. Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients' perspectives and objective disease parameters. Hepatol Res. 2023;53(5):401-8.

  • Demers K, Bak MTJ, Bongers BC, de Vries AC, Jonkers D, Pierik MJ, Stassen LPS. Scoping review on health-related physical fitness in patients with inflammatory bowel disease: Assessment, interventions, and future directions. World J Gastroenterol. 2023;29(38):5406-27.

  • den Boogert EM, Veldhuijzen IK, Generaal E, Prins M, Sonneveld MJ, van der Meer AJ, Zantkuijl P, van Benthem BHB, de Coul E. Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019-2021. BMC Public Health. 2023;23(1):1244.

  • de Jong DM, Gilbert TM, Nooijen LE, Braunwarth E, Ninkovic M, Primavesi F, Malik HZ, Stern N, Sturgess R, Erdmann JI, Voermans RP, Bruno MJ, Koerkamp BG, van Driel L. Preoperative endoscopic biliary drainage by metal versus plastic stents for resectable perihilar cholangiocarcinoma. Gastrointest Endosc. 2023.

  • de Jong DM, Mulder YL, van Dam JL, Groot Koerkamp B, Bruno MJ, de Jonge PJF. Clinical outcome of endoscopic treatment of symptomatic Hepaticojejunal anastomotic strictures after pancreatoduodenectomy. HPB (Oxford). 2023;25(9):1040-6.

  • de Jong DM, Stassen PMC, Groot Koerkamp B, Ellrichmann M, Karagyozov PI, Anderloni A, Kylanpaa L, Webster GJM, van Driel L, Bruno MJ, de Jonge PJF, European Cholangioscopy study g. The role of pancreatoscopy in the diagnostic work-up of intraductal papillary mucinous neoplasms: a systematic review and meta-analysis. Endoscopy. 2023;55(1):25-35.

  • de Jong DM, van de Vondervoort S, Dwarkasing RS, Doukas M, Voermans RP, Verdonk RC, Polak WG, de Jonge J, Koerkamp BG, Bruno MJ, van Driel L. Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making. Endosc Int Open. 2023;11(2):E162-E8.

  • de Rijk FEM, Bruno MJ. Response to Yi et al. Am J Gastroenterol. 2023;118(12):2307-8.

  • de Rijk FEM, Stassen PMC, van der Wiel SE, Boermeester MA, Issa Y, Kempeneers MA, Verdonk RC, Bruno MJ, de Jonge PJF. Long-term outcomes of pancreatoscopy-guided electrohydraulic lithotripsy for the treatment of obstructive pancreatic duct stones. Endosc Int Open. 2023;11(3):E296-E304.

  • de Rijk FEM, van Veldhuisen CL, Besselink MG, van Hooft JE, van Santvoort HC, van Geenen EJM, van Werkhoven CH, de Jonge PJF, Bruno MJ, Verdonk RC, Dutch Pancreatitis Study G. Implementation of an evidence-based management algorithm for patients with chronic pancreatitis (COMBO trial): study protocol for a stepped-wedge cluster-randomized controlled trial. Trials. 2023;24(1):18.

  • de Rijk FEM, van Veldhuisen CL, Kempeneers MA, Issa Y, Boermeester MA, Besselink MG, Kelder JC, van Santvoort HC, de Jonge PJF, Verdonk RC, Bruno MJ, Dutch Pancreatitis Study G. Quality of Life in Patients With Definite Chronic Pancreatitis: A Nationwide Longitudinal Cohort Study. Am J Gastroenterol. 2023;118(8):1428-38.

  • Dekker E, Spaander MCW. The Ideal Screening Test Is the Test That Is Done. Gastroenterology. 2023;165(1):23-5.

  • Dekkers N, Dang H, Vork K, Langers AMJ, van der Kraan J, Westerterp M, Peeters K, Holman FA, Koch AD, de Graaf W, Didden P, Moons LMG, Doornebosch PG, Hardwick JCH, Boonstra JJ. Outcome of Completion Surgery after Endoscopic Submucosal Dissection in Early-Stage Colorectal Cancer Patients. Cancers (Basel). 2023;15(18).

  • Derks ME, Te Groen M, Peters CP, Dijkstra G, de Vries AC, Romkens TE, Horjus CS, de Boer NK, Bemelman WA, Nagtegaal ID, Derikx LA, Hoentjen F, Dutch Initiative on C, Colitis. Endoscopic and surgical treatment outcomes of colitis-associated advanced colorectal neoplasia: a multicenter cohort study. Int J Surg. 2023;109(7):1961-9.

  • Devillers MJC, Pluimers JKF, van Hooff MC, Doukas M, Polak WG, de Man RA, Sonneveld MJ, Boonstra A, den Hoed CM. The Role of PIVKA-II as a Predictor of Early Hepatocellular Carcinoma Recurrence-Free Survival after Liver Transplantation in a Low Alpha-Fetoprotein Population. Cancers (Basel). 2023;16(1).

  • Dings MPG, Manoukian P, Waasdorp C, Quik JSE, Strijker M, Lodestijn SC, van Neerven SM, Moreno LF, de Oliveira RL, Bonsing BA, Bruno MJ, Busch OR, Doukas M, van Eijck CH, Mohammad NH, de Hingh IH, Molenaar QI, Besselink MG, Vermeulen L, Medema JP, van Laarhoven HWM, Bijlsma MF. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. Int J Cancer. 2023;152(3):511-23.

  • Doeve BH, Bakx JAC, Siersema PD, Rosman C, van Grieken NCT, van Berge Henegouwen MI, van Sandick JW, Verheij M, Bijlsma MF, Verhoeven RHA, van Laarhoven HWM. The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer. J Gastroenterol. 2023;58(10):965-77.

  • Eikenboom EL, Moen S, van Leerdam ME, Papageorgiou G, Doukas M, Tanis PJ, Dekker E, Wagner A, Spaander MCW, collaborative investigators from the Dutch Foundation for Detection of Hereditary T. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study. Lancet Gastroenterol Hepatol. 2023;8(12):1106-17.

  • Eikenboom EL, Moen S, van Leeuwen L, Geurts-Giele WRR, Tops CMJ, van Ham TJ, Dinjens WNM, Dubbink HJ, Spaander MCW, Wagner A. Unexplained mismatch repair deficiency: Case closed. HGG Adv. 2023;4(1):100167.

  • Eikenboom EL, Wilting SM, Deger T, Srebniak MI, Van Veghel-Plandsoen M, Boers RG, Boers JB, van IWFJ, Gribnau JH, Atmodimedjo P, Dubbink HJ, Martens JWM, Spaander MCW, Wagner A. Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure? Cancers (Basel). 2023;15(18).

  • Fang Y, Moelker A, den Hoed CM, Porte RJ, Minnee RC, Boehnert MU. Outflow obstruction after living donor liver transplantation managed with a temporary vena cava filter: A case report. Int J Surg Case Rep. 2023;112:108981.

  • Feld JJ, Wahed AS, Fried M, Ghany MG, Di Bisceglie AM, Perrillo RP, Khalili M, Yang X, Belle SH, Janssen HLA, Terrault N, Lok AS, Hepatitis BRN. Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial. Am J Gastroenterol. 2023;118(7):1226-36.

  • Ferrante M, Pouillon L, Manosa M, Savarino E, Allez M, Kapizioni C, Arebi N, Carvello M, Myrelid P, De Vries AC, th Scientific Workshop of the European C, Colitis O, Riviere P, Panis Y, Domenech E. Results of the Eighth Scientific Workshop of ECCO: Prevention and Treatment of Postoperative Recurrence in Patients With Crohn's Disease Undergoing an Ileocolonic Resection With Ileocolonic Anastomosis. J Crohns Colitis. 2023;17(11):1707-22.

  • Fischer SE, de Vries ES, Tushuizen ME, de Boer YS, van der Meer AJP, de Man RA, Brouwer JT, Kuyvenhoven JP, Klemt-Kropp M, Gevers TJG, Tjwa E, Kuiper EMM, Verhagen M, Friederich PW, van Hoek B. Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis. Liver Int. 2023;43(4):855-64.

  • Frederiks CN, van Munster SN, Nieuwenhuis EA, Alvarez Herrero L, Alkhalaf A, Schenk BE, Schoon EJ, Curvers WL, Koch AD, de Jonge PF, Tang T, Nagengast WB, Westerhof J, Houben M, Bergman J, Pouw RE, Weusten B, Dutch Barrett Expert C. Clinical Relevance of Random Biopsies From the Esophagogastric Junction After Complete Eradication of Barrett's Esophagus is Low. Clin Gastroenterol Hepatol. 2023;21(9):2260-9 e9.

  • Fritzsche JA, de Jong DM, Borremans J, Bruno MJ, Van Delden OM, Erdmann JI, Fockens P, de Gooyer PGM, Groot Koerkamp B, Klumpen HJ, Moelker A, Montazeri NSM, Nooijen LE, Ponsioen CY, Van Wanrooij RLJ, van Driel L, Voermans RP. Long-term efficacy of metal versus plastic stents in inoperable perihilar cholangiocarcinoma; a multicenter retrospective propensity score matched comparison. HPB (Oxford). 2023;25(7):798-806.

  • Fu S, Debes JD, Boonstra A. DNA methylation markers in the detection of hepatocellular carcinoma. Eur J Cancer. 2023;191:112960.

  • Fu S, Deger T, Boers RG, Boers JB, Doukas M, Gribnau J, Wilting SM, Debes JD, Boonstra A. Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma. Cancers (Basel). 2023;15(19).

  • Genshaft AS, Subudhi S, Keo A, Sanchez Vasquez JD, Conceicao-Neto N, Mahamed D, Boeijen LL, Alatrakchi N, Oetheimer C, Vilme M, Drake R, Fleming I, Tran N, Tzouanas C, Joseph-Chazan J, Arreola Villanueva M, van de Werken HJG, van Oord GW, Groothuismink ZMA, Beudeker BJ, Osmani Z, Nkongolo S, Mehrotra A, Spittaels K, Feld J, Chung RT, de Knegt RJ, Janssen HLA, Aerssens J, Bollekens J, Hacohen N, Lauer GM, Boonstra A, Shalek AK, Gehring AJ. Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients. Hepatology. 2023;78(5):1525-41.

  • Graus M, de Hingh I, Besselink MG, Bruno MJ, Wilmink JW, de Meijer VE, van Velthuysen MF, Valkenburg-van Iersel LBJ, van der Geest LGM, de Vos-Geelen J, Dutch Pancreatic Cancer G, the C, Cancer NLc, Dutch Nationwide Pathology D, Soncos. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer. HPB (Oxford). 2023;25(10):1195-202.

  • Guo X, Schreurs MWJ, Doukas M, Spaander MCW, Fuhler GM. Letter to the editor commenting on 'decreased anti-parietal cell antibody titer in the advanced phase of autoimmune gastritis' by Nishizawa et al. Scand J Gastroenterol. 2023;58(7):838-9.

  • Guo X, Schreurs MWJ, Marijnissen FE, Mommersteeg MC, Nieuwenburg SAV, Doukas M, Erler NS, Capelle LG, Bruno MJ, Peppelenbosch MP, Spaander MCW, Proregal study g, Fuhler GM. Increased Prevalence of Autoimmune Gastritis in Patients with a Gastric Precancerous Lesion. J Clin Med. 2023;12(19).

  • Goble S, Akambase J, Prieto J, Balderramo D, Ferrer JD, Mattos AZ, Arrese M, Carrera E, Groothuismink ZMA, Oliveira J, Boonstra A, Debes JD. MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort. Dig Dis Sci. 2023;68(11):4212-20.

  • Hallensleben ND, Stassen PMC, Schepers NJ, Besselink MG, Anten MGF, Bakker OJ, Bollen TL, da Costa DW, van Dijk SM, van Dullemen HM, Dijkgraaf MGW, van Eijck B, van Eijck CHJ, Erkelens W, Erler NS, Fockens P, van Geenen EM, van Grinsven J, Hazen WL, Hollemans RA, van Hooft JE, Jansen JM, Kubben F, Kuiken SD, Poen AC, Quispel R, de Ridder RJ, Romkens TEH, Schoon EJ, Schwartz MP, Seerden TCJ, Smeets X, Spanier BWM, Tan A, Thijs WJ, Timmer R, Umans DS, Venneman NG, Verdonk RC, Vleggaar FP, van de Vrie W, van Wanrooij RLJ, Witteman BJ, van Santvoort HC, Bouwense SAW, Bruno MJ, Dutch Pancreatitis Study G. Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study. Gut. 2023;72(8):1534-42.

  • Hirode G, Hansen BE, Chen CH, Su TH, Wong G, Seto WK, Van Hees S, Papatheodoridi M, Brakenhoff SM, Lens S, Choi HSJ, Chien RN, Feld JJ, Forns X, Sonneveld MJ, Papatheodoridis GV, Vanwolleghem T, Yuen MF, Chan HLY, Kao JH, Hsu YC, Cornberg M, Jeng WJ, Janssen HLA, group R-Bs. Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study). Am J Gastroenterol. 2023;118(9):1601-8.

  • Hiensch A, Steenhagen E, van Vulpen JK, Ruurda JP, Nieuwenhuijzen GAP, Kouwenhoven EA, Groenendijk RPR, van der Peet DL, Rosman C, Wijnhoven BPL, van Berge Henegouwen MI, van Laarhoven HWM, van Hillegersberg R, Siersema PD, May AM. Effects of exercise after oesophagectomy on body composition and adequacy of energy and protein intake: PERFECT multicentre randomized controlled trial. BJS Open. 2023;7(4).

  • Hopstaken JS, Daamen LA, Patijn GA, de Vos-Geelen J, Festen S, Bonsing BA, Verheij M, Hermans JJ, Bruno MJ, de Wilde RF, de Hingh I, Besselink MG, Laarhoven K, Stommel MWJ, Dutch Pancreatic Cancer G. Nationwide evaluation of pancreatic cancer networks ten years after the centralization of pancreatic surgery. HPB (Oxford). 2023;25(12):1513-22.

  • Jansen FM, van Linschoten RCA, Kievit W, Smits LJT, Pauwels RWM, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Romkens TEH, Lutgens M, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel M, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan A, Hoentjen F, van der Woude CJ, group Ls. Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial. J Crohns Colitis. 2023;17(11):1771-80.

  • Janssen HLA, Hou J, Asselah T, Chan HLY, Zoulim F, Tanaka Y, Janczewska E, Nahass RG, Bourgeois S, Buti M, Lampertico P, Lenz O, Verbinnen T, Vandenbossche J, Talloen W, Kalmeijer R, Beumont M, Biermer M, Shukla U. Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection. Gut. 2023;72(7):1385-98.

  • Janssen QP, Quispel R, Besselink MG, Bonsing BA, Bruno MJ, Doukas M, Sarasqueta AF, Homs MYV, van Hooft JE, van Tienhoven G, van Velthuysen MF, Verheij J, Voermans RP, Wilmink JW, Groot Koerkamp B, van Eijck CHJ, van Driel L, Dutch Pancreatic Cancer G. Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials. HPB (Oxford). 2023;25(10):1161-8.

  • Jodal HC, Akwiwu EU, Lemmens M, Delis-van Diemen PM, Klotz D, Leon LG, Lakbir S, de Wit M, Fijneman RJA, van Leerdam ME, Dekker E, Spaander MCW, Meijer GA, Loberg M, Coupe VMH, Kalager M, Carvalho B. Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study. Cancer Res Commun. 2023;3(11):2292-301.

 

  • Kamp E, Dinjens WNM, van Velthuysen MF, de Jonge PJF, Bruno MJ, Peppelenbosch MP, de Vries AC. Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis. Gastrointest Endosc. 2023;97(3):456-65 e6.

  • Kim SC, Wallin JJ, Ghosheh Y, Zahoor MA, Sanchez Vasquez JD, Nkongolo S, Fung S, Mendez P, Feld JJ, Janssen HLA, Gehring AJ. Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspirates. JHEP Rep. 2023;5(9):100817.

  • Kreijne JE, Goetgebuer RL, Erler NS, De Boer NK, Siebers AG, Dijkstra G, van Kemenade FA, Hoentjen F, Oldenburg B, van der Meulen AE, Ponsioen CIJ, Pierik MJ, van der Woude CJ, de Vries AC, Dutch Initiative on C, Colitis. Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease. Aliment Pharmacol Ther. 2023;58(2):207-17.

  • Kamp E, Dinjens WNM, van Velthuysen MF, de Jonge PJF, Bruno MJ, Peppelenbosch MP, de Vries AC. Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis. Gastrointest Endosc. 2023;97(3):456-65 e6.

  • Kastelijn JB, van de Pavert YL, Besselink MG, Fockens P, Voermans RP, van Wanrooij RLJ, de Wijkerslooth TR, Curvers WL, de Hingh I, Bruno MJ, Koerkamp BG, Patijn GA, Poen AC, van Hooft JE, Inderson A, Mieog JSD, Poley JW, Bijlsma A, Lips DJ, Venneman NG, Verdonk RC, van Dullemen HM, Hoogwater FJH, Frederix GWJ, Molenaar IQ, Welsing PMJ, Moons LMG, van Santvoort HC, Vleggaar FP, Dutch Pancreatic Cancer G. Endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for palliation of malignant gastric outlet obstruction (ENDURO): study protocol for a randomized controlled trial. Trials. 2023;24(1):608.

  • Kempeneers MA, Issa Y, Bruno MJ, van Santvoort HC, Besselink MG, Boermeester MA, Dijkgraaf MG, Dutch Pancreatitis Study G. Cost-effectiveness of Early Surgery Versus Endoscopy-first Approach for Painful Chronic Pancreatitis in the ESCAPE Trial. Ann Surg. 2023;277(4):e878-e84.

  • Kempers EK, van Kwawegen CB, de Meris J, Spaander MCW, Schols SEM, Ypma PF, Heubel-Moenen F, van Vulpen LFD, Coppens M, van der Bom JG, Fijnvandraat K, Meijer K, Eikenboom J, Gouw SC, Leebeek FWG, Kruip M. Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients. J Thromb Haemost. 2023;21(5):1177-88.

  • Koch AD. Competency assessment: a journey of lifelong learning. Endoscopy. 2023;55(9):857-8.

  • Koopmann BDM, Dunnewind N, van Duuren LA, Lansdorp-Vogelaar I, Naber SK, Cahen DL, Bruno MJ, de Kok I, Dutch Pancreatic Cancer G. The Natural Disease Course of Pancreatic Cyst-Associated Neoplasia, Dysplasia, and Ductal Adenocarcinoma: Results of a Microsimulation Model. Gastroenterology. 2023;165(6):1522-32.

  • Koopmann BDM, Omidvari AH, Lansdorp-Vogelaar I, Cahen DL, Bruno MJ, de Kok I. The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies. Int J Cancer. 2023;152(8):1570-80.

  • Kortlever TL, van der Vlugt M, Duijkers FAM, Masclee A, Kraaijenhagen R, Spaander MCW, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E. Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme. Br J Cancer. 2023;129(5):791-6.

  • Kwakman JA, Poley MJ, Vos MC, Bruno MJ. Single-use duodenoscopes compared with reusable duodenoscopes in patients carrying multidrug-resistant microorganisms: a break-even cost analysis. Endosc Int Open. 2023;11(6):E571-E80.

  • Kwakman JA, Vos MC, Bruno MJ. Investigation of the efficacy of an innovative endoscope drying and storage method in a simulated ERCP setting. Endosc Int Open. 2023;11(4):E419-E25.

  • Kwakman JA, Vos MC, Bruno MJ. Higher yield in duodenoscope cultures collected with addition of neutralizing agent. J Hosp Infect. 2023;132:28-35.

  • Lantinga MA, van Kleef LA, den Hoed CM, De Knegt RJ. Spleen Stiffness Measurement Across the Spectrum of Liver Disease Patients in Real-World Practice. J Clin Exp Hepatol. 2023;13(3):414-27.

  • Levink IJM, Jaarsma SC, Koopmann BDM, van Riet PA, Overbeek KA, Meziani J, Sprij M, Casadei R, Ingaldi C, Polkowski M, Engels MML, van der Waaij LA, Carrara S, Pando E, Vornhulz M, Honkoop P, Schoon EJ, Laukkarinen J, Bergmann JF, Rossi G, van Vilsteren FGI, van Berkel AM, Tabone T, Schwartz MP, Tan A, van Hooft JE, Quispel R, van Soest E, Czacko L, Bruno MJ, Cahen DL, group PA-rw. The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program. United European Gastroenterol J. 2023;11(7):601-11.

  • Levink IJM, Jansen M, Azmani Z, van IW, van Marion R, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ. Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer. Int J Mol Sci. 2023;24(17).

  • Levink IJM, Srebniak MI, De Valk WG, van Veghel-Plandsoen MM, Wagner A, Cahen DL, Fuhler GM, Bruno MJ. An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer. Int J Mol Sci. 2023;24(6).

  • Li P, Pachis ST, Xu G, Schraauwen R, Incitti R, de Vries AC, Bruno MJ, Peppelenbosch MP, Alam I, Raymond K, Pan Q. Mpox virus infection and drug treatment modelled in human skin organoids. Nat Microbiol. 2023;8(11):2067-79.

  • Lieshout R, Kamp E, Verstegen MMA, Doukas M, Dinjens WNM, Koten K, JNM IJ, Bruno MJ, Peppelenbosch MP, van der Laan LJW, de Vries AC. Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A. Int J Cancer. 2023;152(12):2607-14.

  • Li P, Du Z, Lamers MM, Incitti R, Tejeda-Mora H, Li S, Schraauwen R, van den Bosch TPP, de Vries AC, Alam IS, Haagmans BL, Hoogduijn MJ, Pan Q. Mpox virus infects and injures human kidney organoids, but responding to antiviral treatment. Cell Discov. 2023;9(1):34.

  • Li P, Li J, Ayada I, Avan A, Zheng Q, Peppelenbosch MP, de Vries AC, Pan Q. Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks. J Infect Dis. 2023;228(4):391-401.

  • Li P, Pachis ST, Xu G, Schraauwen R, Incitti R, de Vries AC, Bruno MJ, Peppelenbosch MP, Alam I, Raymond K, Pan Q. Mpox virus infection and drug treatment modelled in human skin organoids. Nat Microbiol. 2023;8(11):2067-79.

  • Li Y, Wang Y, Li Y, de Vries AC, Li P, Peppelenbosch MP, Pan Q. Seasonal coronavirus infections trigger NLRP3 inflammasome activation in macrophages but is therapeutically targetable. Antiviral Res. 2023;216:105674.

  • Li Y, Zhang R, Wang Y, Li P, Li Y, Janssen HLA, de Man RA, Peppelenbosch MP, Ou X, Pan Q. Hepatitis E virus infection remodels the mature tRNAome in macrophages to orchestrate NLRP3 inflammasome response. Proc Natl Acad Sci U S A. 2023;120(25):e2304445120.

  • Lieshout R, Kamp E, Verstegen MMA, Doukas M, Dinjens WNM, Koten K, JNM IJ, Bruno MJ, Peppelenbosch MP, van der Laan LJW, de Vries AC. Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A. Int J Cancer. 2023;152(12):2607-14.

  • Lim YS, Chan HLY, Ahn SH, Seto WK, Ning Q, Agarwal K, Janssen HLA, Pan CQ, Chuang WL, Izumi N, Fung S, Shalimar, Brunetto M, Hui AJ, Chang TT, Lim SG, Abramov F, Flaherty JF, Wang H, Yee LJ, Kao JH, Gane E, Hou J, Buti M. Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B. JHEP Rep. 2023;5(10):100847.

  • Lucifora J, Alfaiate D, Pons C, Michelet M, Ramirez R, Fusil F, Amirache F, Rossi A, Legrand AF, Charles E, Vegna S, Farhat R, Rivoire M, Passot G, Gadot N, Testoni B, Bach C, Baumert TF, Hyrina A, Beran RK, Zoulim F, Boonstra A, Buning H, Verrier ER, Cosset FL, Fletcher SP, Salvetti A, Durantel D. Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms. J Hepatol. 2023;78(5):958-70.

  • Majeed NA, Alawad AS, Liem KS, Takyar V, Alter H, Feld JJ, Janssen HLA, Ghany MG. Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy. Dig Dis Sci. 2023;68(7):3193-8.

  • Malahe SRK, Hoek RAS, Dalm V, Broers AEC, den Hoed CM, Manintveld OC, Baan CC, van Deuzen CM, Papageorgiou G, Bax HI, Van Kampen JJ, Hellemons ME, Kho MML, de Vries RD, Molenkamp R, Reinders MEJ, Rijnders BJA. Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study. Clin Infect Dis. 2023;76(3):e172-e8.

  • Malahe SRK, van Kampen JJA, Manintveld OC, Hoek RAS, den Hoed CM, Baan CC, Kho MML, Verjans G. Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients. Viruses. 2023;15(7).

  • Meester RGS, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, de Jonge L, Toes-Zoutendijk E, Kooyker A, Nieboer D, Ramakers CR, Spaander MCW, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Nagtegaal ID, Dekker E, van Leerdam ME, Lansdorp-Vogelaar I, Dutch colorectal cancer screening working g. Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model. Gut. 2023;72(1):101-8.

  • Mommersteeg MC, Nieuwenburg SAV, Wolters LMM, Roovers B, van Vuuren HAJ, Verhaar AP, Bruno MJ, Kuipers EJ, Peppelenbosch MP, Spaander MCW, Fuhler GM. The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance. United European Gastroenterol J. 2023;11(9):894-903.

  • Mendez Romero A, van der Holt B, Willemssen F, de Man RA, Heijmen BJM, Habraken S, Westerveld H, van Delden OM, Klumpen HJ, Tjwa E, Braam PM, Jenniskens SFM, Vanwolleghem T, Weytjens R, d'Archambeau O, de Vos-Geelen J, Buijsen J, van der Leij C, den Toom W, Sprengers D, JNM IJ, Moelker A. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial). Int J Radiat Oncol Biol Phys. 2023;117(1):45-52.

  • Minciuna I, den Hoed C, van der Meer AJ, Sonneveld MJ, Sprengers D, de Knegt RJ, de Jonge J, Maan R, Polak WG, Darwish Murad S. The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular Complications. Transpl Int. 2023;36:11611.

  • Mulder MB, Busschbach JV, van Hoek B, van den Berg AP, Polak WG, Alwayn IPJ, de Winter BCM, Verhey-Hart E, Erler NS, den Hoed CM, Metselaar HJ. Health-related Quality of Life and Fatigue in Liver Transplant Recipients Receiving Tacrolimus Versus Sirolimus-based Immunosuppression: Results From a Randomized Trial. Transplantation. 2023;107(12):2545-53.

  • Mulder MB, van Hoek B, van den Berg AP, Polak WG, Alwayn IPJ, de Jong KP, de Winter BCM, Verhey-Hart E, Erler NS, den Hoed CM, Metselaar HJ. Three-year results of renal function in liver transplant recipients on low-dose sirolimus and tacrolimus: a multicenter, randomized, controlled trial. Liver Transpl. 2023;29(2):184-95.

  • Murillo Perez CF, Gerussi A, Trivedi PJ, Corpechot C, van der Meer AJ, Maria Battezzati P, Lindor KD, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Tanaka A, Ma X, Mason AL, Gulamhusein A, Ponsioen CY, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Pares A, Janssen HLA, Hirschfield GM, Hansen BE, Invernizzi P, Lammers WJ, Group GPS. Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe. Eur J Gastroenterol Hepatol. 2023;35(1):112-9.

  • Murillo Perez CF, Ioannou S, Hassanally I, Trivedi PJ, Corpechot C, van der Meer AJ, Lammers WJ, Battezzati PM, Lindor KD, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Mason AL, Gulamhusein A, Ponsioen CY, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Pares A, Londono MC, Janssen HLA, Invernizzi P, Vuppalanchi R, Hirschfield GM, Hansen BE, Levy C, Global PBCSG. Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival. Liver Int. 2023;43(7):1497-506.

  • Nilsson JE, de Graaf W, Koch AD. Endoscopic resection of upper gastrointestinal lesions using the colonic Ovesco full-thickness resection device: Retrospective observational case series of 22 cases. Endosc Int Open. 2023;11(1):E19-E23.

  • Osmani Z, Boonstra A. Recent Insights into the Role of B Cells in Chronic Hepatitis B and C Infections. Pathogens. 2023;12(6).

  • Patmore LA, Katwaroe WK, van der Spek D, Choi HSJ, Patel K, Brakenhoff S, van der Meer AJ, Brouwer WP, van Kleef LA, de Knegt RJ, Hansen BE, de Man RA, Feld JJ, Janssen HLA, Sonneveld MJ. Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2023;21(12):3089-96 e1.

  • Patmore LA, van der Eijk AA, Janssen HLA, de Man RA, Sonneveld MJ. Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies. J Hepatol. 2023.

  • Pauwels RWM, Ten Bokkel Huinink S, van der Woude CJ, Doukas M, Oudijk L, de Vries AC. Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease. Scand J Gastroenterol. 2023;58(9):980-7.

  • Proietti E, Pauwels RWM, de Vries AC, Orecchini E, Volpi C, Orabona C, Peppelenbosch MP, Fuhler GM, Mondanelli G. Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice. Int J Tryptophan Res. 2023;16:11786469231153109.

  • Proietti E, Pauwels RWM, van der Woude CJ, Doukas M, Oudijk L, Peppelenbosch MP, Grohmann U, Crombag MBS, de Vries AC, Fuhler GM. Ustekinumab Tissue and Serum Levels in Patients With Crohn's Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction. Inflamm Bowel Dis. 2023;29(7):1038-46.

  • Pullen LCE, Noortman WA, Triemstra L, de Jongh C, Rademaker FJ, Spijkerman R, Kalisvaart GM, Gertsen EC, de Geus-Oei LF, Tolboom N, de Steur WO, Dantuma M, Slart R, van Hillegersberg R, Siersema PD, Ruurda JP, van Velden FHP, Vegt E, On Behalf Of The Plastic Study G. Prognostic Value of [(18)F]FDG PET Radiomics to Detect Peritoneal and Distant Metastases in Locally Advanced Gastric Cancer-A Side Study of the Prospective Multicentre PLASTIC Study. Cancers (Basel). 2023;15(11).

  • Quispel R, Schutz HM, Keultjes AWP, Erler NS, Janssen QP, van Hooft JE, Venneman NG, Honkoop P, Hol L, Scheffer RC, Bisseling TM, Voermans RP, Vleggaar FP, Schwartz MP, Verdonk RC, Hoge CV, Kuiken SD, Curvers WL, van Vilsteren FGI, Poen AC, Spanier MB, Bruggink AH, Smedts FM, van Velthuysen MF, van Eijck CH, Besselink MG, Veldt BJ, Koerkamp BG, van Driel L, Bruno MJ, Dutch Pancreatic Cancer G, Team QUiE. Diagnostic accuracy of endoscopic ultrasonography-guided tissue acquisition prior to resection of pancreatic carcinoma: a nationwide analysis. HPB (Oxford). 2023;25(11):1438-45.

  • Rijpma-Jacobs L, van der Vlies E, Meek DB, Bollen TL, Siersema PD, Weusten B, Intven M, van Lelyveld N, Los M. Pelvic insufficiency fractures and pelvic bone metastases after neoadjuvant (chemo)radiotherapy for rectal cancer. Acta Oncol. 2023;62(10):1295-300.

  • Rodrigues-Pinto E, Ferreira-Silva J, Siersema PD. How to Prevent and Treat the Most Frequent Adverse Events Related to Luminal Dilation and Stenting in Benign Disease. Am J Gastroenterol. 2023;118(9):1521-7.

  • Rodriguez de Santiago E, van Tilburg L, Deprez PH, Pioche M, Pouw RE, Bourke MJ, Seewald S, Weusten B, Jacques J, Leblanc S, Barreiro P, Lemmers A, Parra-Blanco A, Kuttner-Magalhaes R, Libanio D, Messmann H, Albeniz E, Kaminski MF, Mohammed N, Ramos-Zabala F, Herreros-de-Tejada A, Huchima Koecklin H, Wallenhorst T, Santos-Antunes J, Cunha Neves JA, Koch AD, Ayari M, Garces-Duran R, Ponchon T, Rivory J, Bergman J, Verheij EPD, Gupta S, Groth S, Lepilliez V, Franco AR, Belkhir S, White J, Ebigbo A, Probst A, Legros R, Pilonis ND, de Frutos D, Munoz Gonzalez R, Dinis-Ribeiro M. Western outcomes of circumferential endoscopic submucosal dissection for early esophageal squamous cell carcinoma. Gastrointest Endosc. 2023.

  • Roumans CAM, van der Bogt RD, Nieboer D, Steyerberg EW, Rizopoulos D, Lansdorp-Vogelaar I, Biermann K, Bruno MJ, Spaander MCW. Clinical consequences of nonadherence to Barrett's esophagus surveillance recommendations: a Multicenter prospective cohort study. Dis Esophagus. 2023;36(8).

  • Sebastian S, Segal JP, Hedin C, Pellino G, Kotze PG, Adamina M, Campmans-Kuijpers M, Davies J, de Vries AC, Casbas AG, El-Hussuna A, Juillerat P, Meade S, Millan M, Spinelli A. ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD. J Crohns Colitis. 2023;17(2):153-69.

  • Sleutjes JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC. Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation. Inflamm Bowel Dis. 2023;29(4):531-8.

  • Sleutjes JAM, van der Woude CJ, Verploegh PJP, Aribas E, Kavousi M, Roeters van Lennep JE, de Vries AC. Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population. Eur J Prev Cardiol. 2023;30(15):1615-22.

  • Sijben J, Peters Y, Rainey L, Gashi M, Broeders MJM, Siersema PD. Professionals' views on the justification for esophageal adenocarcinoma screening: A systematic literature search and qualitative analysis. Prev Med Rep. 2023;34:102264.

  • Sissingh NJ, Nagelhout A, Besselink MG, Boermeester MA, Bouwense SAW, Bruno MJ, Fockens P, Goudriaan AE, Rodriquez-Girondo MDM, van Santvoort HC, Sijbom M, van Weert H, van Hooft JE, Umans DS, Verdonk RC, Dutch Pancreatitis Study G. Structured alcohol cessation support program versus current practice in acute alcoholic pancreatitis (PANDA): Study protocol for a multicentre cluster randomised controlled trial. Pancreatology. 2023;23(8):942-8.

  • Spaander MCW, Zauber AG, Syngal S, Blaser MJ, Sung JJ, You YN, Kuipers EJ. Young-onset colorectal cancer. Nat Rev Dis Primers. 2023;9(1):21.

  • Sperna Weiland CJ, Verschoor EC, Poen AC, Smeets X, Venneman NG, Bhalla A, Witteman BJM, Timmerhuis HC, Umans DS, van Hooft JE, Bruno MJ, Fockens P, Verdonk RC, Drenth JPH, van Geenen EJM, Dutch Pancreatitis Study G. Suspected common bile duct stones: reduction of unnecessary ERCP by pre-procedural imaging and timing of ERCP. Surg Endosc. 2023;37(2):1194-202.

  • Stefanovic S, Adler DG, Arlt A, Baron TH, Binmoeller KF, Bronswijk M, Bruno MJ, Chevaux JB, Crino SF, Degroote H, Deprez PH, Draganov PV, Eisendrath P, Giovannini M, Perez-Miranda M, Siddiqui AA, Voermans RP, Yang D, Hindryckx P. International Consensus Recommendations for Safe Use of LAMS for On- and Off-Label Indications Using a Modified Delphi Process. Am J Gastroenterol. 2023.

  • Snijders R, Stoelinga AEC, Gevers TJG, Pape S, Biewenga M, Tushuizen ME, Verdonk RC, de Jonge HJM, Vrolijk JM, Bakker SF, Vanwolleghem T, de Boer YS, Baven Pronk M, Beuers U, van der Meer AJ, Gerven N, Sijtsma MGM, van Eijck BC, van IMC, van Herwaarden M, van den Brand FF, Korkmaz KS, van den Berg AP, Guichelaar MMJ, Levens AD, van Hoek B, Drenth JPH, Dutch Autoimmune Hepatitis Working G. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis. J Hepatol. 2023.

  • Sonneveld MJ, Brouwer WP, Janssen HLA. Treatment of diabetes mellitus in patients with chronic hepatitis B: Are SGLT2 inhibitors hitting the sweet spot? Hepatology. 2023;78(5):1334-6.

  • Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bommel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Brunetto M, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B, group Cs. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study. JHEP Rep. 2023;5(8):100790.

  • Straatmijer T, van Schaik FDM, Bodelier AGL, Visschedijk M, de Vries AC, Ponsioen CY, Pierik M, van Bodegraven AA, West RL, de Boer NKH, Srivastava N, Romkens TEH, Hoekstra J, Oldenburg B, Dijkstra G, van der Woude JC, Lowenberg M, Mujagic Z, Biemans VBC, van der Meulen-de Jong AE, Duijvestein M. Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry. Aliment Pharmacol Ther. 2023;57(1):117-26.

  • Ten Bokkel Huinink S, Beelen EMJ, Ten Bokkel Huinink T, Hoentjen F, A GLB, Dijkstra G, Romberg-Camps M, de Boer NK, Stassen LPS, van der Meulen AE, West R, van Ruler O, van der Woude CJ, de Vries AC, Dutch Initiative on C, Colitis. Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy. Eur J Gastroenterol Hepatol. 2023;35(1):45-51.

  • Ten Kate CA, Teunissen NM, van Rosmalen J, Kamphuis LS, van Wijk MP, Joosten M, van Tuyll van Serooskerken ES, Wijnen R, H IJ, Rietman AB, Spaander MCW. Development and validation of a condition-specific quality of life instrument for adults with esophageal atresia: the SQEA questionnaire. Dis Esophagus. 2023;36(6).

  • Theunissen F, Lantinga MA, Ter Borg PCJ, Ouwendijk RJT, Siersema PD, Bruno MJ, Trans ITfsg. Efficacy of different bowel preparation regimen volumes for colorectal cancer screening and compliance with European Society of Gastrointestinal Endoscopy performance measures. United European Gastroenterol J. 2023;11(5):448-57.

  • Timmerhuis HC, van den Berg FF, Noorda PC, van Dijk SM, van Grinsven J, Sperna Weiland CJ, Umans DS, Mohamed YA, Curvers WL, Bouwense SAW, Hadithi M, Inderson A, Issa Y, Jansen JM, de Jonge PJF, Quispel R, Schwartz MP, Stommel MWJ, Tan A, Venneman NG, Besselink MG, Bruno MJ, Bollen TL, Sieswerda E, Verdonk RC, Voermans RP, van Santvoort HC, Dutch Pancreatitis Study G. Overuse and Misuse of Antibiotics and the Clinical Consequence in Necrotizing Pancreatitis: An Observational Multicenter Study. Ann Surg. 2023;278(4):e812-e9.

  • Timmerhuis HC, van Dijk SM, Hollemans RA, Sperna Weiland CJ, Umans DS, Boxhoorn L, Hallensleben NH, van der Sluijs R, Brouwer L, van Duijvendijk P, Kager L, Kuiken S, Poley JW, de Ridder R, Romkens TEH, Quispel R, Schwartz MP, Tan A, Venneman NG, Vleggaar FP, van Wanrooij RLJ, Witteman BJ, van Geenen EJ, Molenaar IQ, Bruno MJ, van Hooft JE, Besselink MG, Voermans RP, Bollen TL, Verdonk RC, van Santvoort HC, Dutch Pancreatitis Study G. Short-term and Long-term Outcomes of a Disruption and Disconnection of the Pancreatic Duct in Necrotizing Pancreatitis: A Multicenter Cohort Study in 896 Patients. Am J Gastroenterol. 2023;118(5):880-91.

  • Timmerhuis HC, van Dijk SM, Hollemans RA, Umans DS, Sperna Weiland CJ, Besselink MG, Bouwense SAW, Bruno MJ, van Duijvendijk P, van Eijck CHJ, Issa Y, Mieog JSD, Molenaar IQ, Stommel MWJ, Bollen TL, Voermans RP, Verdonk RC, van Santvoort HC, Dutch Pancreatitis Study G. Perforation and Fistula of the Gastrointestinal Tract in Patients With Necrotizing Pancreatitis: A Nationwide Prospective Cohort. Ann Surg. 2023;278(2):e284-e92.

  • Toes-Zoutendijk E, de Jonge L, van Iersel CA, Spaander MCW, van Vuuren AJ, van Kemenade F, Ramakers CR, Dekker E, Nagetaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis. Gut. 2023;72(7):1319-25.

  • Ubels S, Matthee E, Verstegen M, Klarenbeek B, Bouwense S, van Berge Henegouwen MI, Daams F, Dekker JWT, van Det MJ, van Esser S, Griffiths EA, Haveman JW, Nieuwenhuijzen G, Siersema PD, Wijnhoven B, Hannink G, van Workum F, Rosman C, group TEc. Erratum to "Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue" [Eur J Surg Oncol 49 (5) (May 2023) 974-982]. Eur J Surg Oncol. 2023;49(9):106993.

  • Ubels S, Matthee E, Verstegen M, Klarenbeek B, Bouwense S, van Berge Henegouwen MI, Daams F, Dekker JWT, van Det MJ, van Esser S, Griffiths EA, Haveman JW, Nieuwenhuijzen G, Siersema PD, Wijnhoven B, Hannink G, van Workum F, Rosman C, group TEc, Writing C, Heisterkamp J, Polat F, Schouten J, Singh P, Study c. Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue. Eur J Surg Oncol. 2023;49(5):974-82.

  • Ubels S, Verstegen MHP, Klarenbeek BR, Bouwense S, van Berge Henegouwen MI, Daams F, van Det MJ, Griffiths EA, Haveman JW, Heisterkamp J, Nieuwenhuijzen G, Polat F, Schouten J, Siersema PD, Singh P, Wijnhoven B, Hannink G, van Workum F, Rosman C, Group TE-EC. Treatment of anastomotic leak after oesophagectomy for oesophageal cancer: large, collaborative, observational TENTACLE cohort study. Br J Surg. 2023;110(7):852-63.

  • Umans DS, Timmerhuis HC, Anten MGF, Bhalla A, Bijlsma RA, Boxhoorn L, Brink MA, Bruno MJ, Curvers WL, van Eijck BC, Erkelens GW, van Geenen EJM, Hazen WL, Hoge CV, Hol L, Inderson A, Kager LM, Kuiken SD, Perk LE, Quispel R, Romkens TEH, Sperna Weiland CJ, Thijssen AY, Venneman NG, Verdonk RC, van Wanrooij RLJ, Witteman BJ, Besselink MG, van Hooft JE. Prospective multicentre study of indications for surgery in patients with idiopathic acute pancreatitis following endoscopic ultrasonography (PICUS). Br J Surg. 2023;110(12):1877-82.

  • Valkema MJ, Spaander MCW, Boonstra JJ, van Dieren JM, Hazen WL, Erkelens GW, Holster IL, van der Linden A, van der Linde K, Oostenbrug LE, Quispel R, Schoon EJ, Siersema PD, Doukas M, Eyck BM, van der Wilk BJ, van der Sluis PC, Wijnhoven BPL, Lagarde SM, van Lanschot JJB. Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon. Br J Surg. 2023;110(10):1381-6.

  • van de Pol N, Pan Q, Derikx L, Bakker L, van der Woude CJ, de Vries AC. SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2023;16:17562848231174295.

  • van den Beukel MD, Stoelinga AEC, van der Meer AJ, van der Meulen S, Zhang L, Tushuizen ME, van Hoek B, Trouw LA. Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment. Front Med (Lausanne). 2023;10:1297191.

  • van den Beukel MD, Stoelinga AEC, van der Meer AJ, van der Meulen S, Zhang L, Tushuizen ME, van Hoek B, Trouw LA. Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment. Front Med (Lausanne). 2023;10:1195747.

  • van der Spek DPC, Katwaroe WK, van Kleef LA, Brakenhoff S, de Man RA, de Knegt RJ, van der Meer AJ, Sonneveld MJ. Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980-2020. Eur J Intern Med. 2023;107:86-92.

  • van Kleef LA, de Knegt RJ, Ayada I, Pan Q, Brouwer WP. The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population. Hepatol Commun. 2023;7(4).

  • van Kleef LA, de Knegt RJ, Brouwer WP. Reply. Hepatology. 2023;77(3):E45-E6.

  • van Kleef LA, de Knegt RJ, Brouwer WP. Reply. Hepatology. 2023;77(4):E69-E70.

  • van Kleef LA, de Knegt RJ, Brouwer WP. Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality. Hepatology. 2023;77(3):942-8.

  • van Kleef LA, Sonneveld MJ, de Knegt RJ. Reply: Is there survival bias? The etiologic analysis for the negative association between fatty liver and mortality in the elderly populations. Hepatology. 2023;78(2):E31-E2.

  • van Kleef LA, Sonneveld MJ, de Knegt RJ. Reply. Hepatology. 2023;77(2):E30-E1.

  • van Kleef LA, Sonneveld MJ, de Knegt RJ. Reply. Hepatology. 2023;77(3):E41-E2.

  • van Kleef LA, Sonneveld MJ, de Knegt RJ. Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population. Clin Gastroenterol Hepatol. 2023;21(1):238-9.

  • van Kleef LA, Sonneveld MJ, Kavousi M, Ikram MA, de Man RA, de Knegt RJ. Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study. Hepatology. 2023;77(2):585-93.

  • van Kleef LA, Sonneveld MJ, Zhu F, Ikram MA, Kavousi M, de Knegt RJ. Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study. Liver Int. 2023;43(5):1000-7.

  • van de Schootbrugge-Vandermeer HJ, Kooyker AI, Wisse PHA, Nagtegaal ID, Geuzinge HA, Toes-Zoutendijk E, de Jonge L, Breekveldt ECH, van Vuuren AJ, van Kemenade FJ, Ramakers CRB, Dekker E, Lansdorp-Vogelaar I, Spaander MCW, van Leerdam ME. Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program. Endoscopy. 2023;55(12):1061-9.

  • van de Schootbrugge-Vandermeer HJ, Lansdorp-Vogelaar I, de Jonge L, van Vuuren AJ, Dekker E, Spaander MCW, Ramakers CRB, Nagtegaal ID, van Kemenade FJ, van Leerdam ME, Toes-Zoutendijk E. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme. Eur J Cancer. 2023;190:112942.

  • van der Ploeg K, Bruno MJ. Search better and you will find more: an important lesson in endoscope contamination. Endosc Int Open. 2023;11(4):E366-E7.

  • van der Ploeg K, Bruno MJ. The potential benefits of an automated flexible endoscope channel brushing system for manual cleaning of endoscopes. Endoscopy. 2023;55(7):643-4.

  • van der Schoor AS, Severin JA, Klaassen CHW, Gommers D, Bruno MJ, Hendriks JM, Voor In 't Holt AF, Vos MC. Environmental contamination with highly resistant microorganisms after relocating to a new hospital building with 100% single-occupancy rooms: A prospective observational before-and-after study with a three-year follow-up. Int J Hyg Environ Health. 2023;248:114106.

  • van der Schoor AS, Severin JA, Klaassen CHW, van den Akker JPC, Bruno MJ, Hendriks JM, Vos MC, Voor In 't Holt AF. Universal screening or a universal risk assessment combined with risk-based screening for multidrug-resistant microorganisms upon admission: Comparing strategies. PLoS One. 2023;18(7):e0289163.

  • van der Schoor AS, Voor In 't Holt AF, Zandijk WHA, Bruno MJ, Gommers D, van den Akker JPC, Hendriks JM, Severin JA, Klaassen CHW, Vos MC. Dynamics of Staphylococcus aureus in patients and the hospital environment in a tertiary care hospital in the Netherlands. Antimicrob Resist Infect Control. 2023;12(1):148.

  • van der Wiel SE, Rauws E, Van Gool S, Wang D, Hu B, Kylanpaa L, Webster GJM, James M, Koch AD, Bruno M. Impact of ERCP simulator training on early ERCP learning curves of novice trainees: a cohort study. Endosc Int Open. 2023;11(8):E690-E6.

  • van der Zijden CJ, Lagarde SM, Hermus M, Kranenburg LW, van Lanschot JJB, Mostert B, Nuyttens J, Oudijk L, van der Sluis PC, Spaander MCW, Valkema MJ, Valkema R, Wijnhoven BPL, group S-s. A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2. BMC Cancer. 2023;23(1):327.

  • van Tilburg L, Spaander MCW, Bruno MJ, Oudijk L, Heij LR, Doukas M, Koch AD. Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands. Dis Esophagus. 2023;36(12).

  • van Tilburg L, van de Ven SEM, de Jonge PJF, de Graaf W, Spaander MCW, Nikkessen S, Hardillo JA, Sewnaik A, Monserez DA, Mast H, Keereweer S, Bruno MJ, Baatenburg de Jong RJ, Koch AD. Endoscopic screening of the upper gastrointestinal tract for second primary tumors in patients with head and neck cancer in a Western country. Endoscopy. 2023;55(11):981-90.

  • van Tilburg L, van de Ven SEM, Spaander MCW, van Kleef LA, Cornelissen R, Bruno MJ, Koch AD. Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2023;149(5):1811-23.

  • van Toledo D, Breekveldt ECH, JEG IJ, van Vuuren AJ, van Kemenade FJ, Ramakers C, Nagtegaal ID, van Leerdam ME, Spaander MCW, Lansdorp-Vogelaar I, Toes-Zoutendijk E, Dekker E. Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population. Endoscopy. 2023;55(6):526-34.

  • van Toledo D, JEG IJ, Spaander MCW, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I, Dekker E. Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening. EClinicalMedicine. 2023;61:102066.

  • Van Veldhuisen CL, Sissingh NJ, Boxhoorn L, van Dijk SM, van Grinsven J, Verdonk RC, Boermeester MA, Bouwense SAW, Bruno MJ, Cappendijk VC, van Duijvendijk P, van Eijck CHJ, Fockens P, van Goor H, Hadithi M, Haveman JW, Jacobs M, Jansen JM, Kop M, Manusama ER, Mieog J, Molenaar IQ, Nieuwenhuijs VB, Poen AC, Poley JW, Quispel R, Romkens T, Schwartz MP, Seerden TC, Dijkgraaf M, Stommel M, Straathof J, Venneman NG, Voermans RP, van Hooft JE, van Santvoort HC, Besselink MG, Dutch Pancreatitis Study G. Long-Term Outcome of Immediate Versus Postponed Intervention in Patients With Infected Necrotizing Pancreatitis (POINTER): Multicenter Randomized Trial. Ann Surg. 2023.

  • van Velzen MJM, Braemer M, Nieuwenhuijzen GAP, van Sandick JW, Siersema PD, Ruurda JP, Verheij M, Spaander MCW, Beerepoot LV, Haj Mohammad N, van Laarhoven HWM, Verhoeven RHA. Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer. JAMA Netw Open. 2023;6(8):e2330018.

  • van Linschoten RCA, Jansen FM, Pauwels RWM, Smits LJT, Atsma F, Kievit W, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Romkens TEH, Lutgens M, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel M, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan A, van der Woude CJ, Hoentjen F, group Ls, the Dutch Initiative on C, Colitis. Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(4):343-55.

  • van Munster KN, Mol B, Goet JC, van Munster SN, Weersma RK, de Vries AC, van der Meer AJ, Inderson A, Drenth JP, van Erpecum KJ, Boonstra K, Beuers U, Dijkgraaf MGW, Ponsioen CY, Epi PSCSG. Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up study. Liver Int. 2023;43(3):639-48.

  • van Velsen LM, Sonneveld MJ, van Erpecum KJ. Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B? Hepatobiliary Surg Nutr. 2023;12(6):919-22.

  • Verbinnen T, Talloen W, Janssen HLA, Zoulim F, Shukla U, Vandenbossche JJ, Biermer M, De Meyer S, Lenz O. Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study. Antiviral Res. 2023;216:105660.

  • Vu Trung K, Heise C, Abou-Ali E, Auriemma F, Karam E, van der Wiel SE, Bruno MJ, Caillol F, Giovannini M, Masaryk V, Will U, Anderloni A, Perez-Cuadrado-Robles E, Dugic A, Meier B, Paik WH, Petrone MC, Wichmann D, Dinis-Ribeiro M, Goncalves TC, Wedi E, Schmidt A, Gulla A, Hoffmeister A, Rosendahl J, Ratone JP, Saadeh R, Repici A, Deprez P, Sauvanet A, Souche FR, Fabre JM, Muehldorfer S, Caca K, Lohr M, Michl P, Krug S, Regner S, Gaujoux S, Hollenbach M. Endoscopic papillectomy for ampullary lesions of minor papilla. Gastrointest Endosc. 2023.

  • Wang Y, Li P, Lavrijsen M, Rottier RJ, den Hoed CM, Bruno MJ, Kamar N, Peppelenbosch MP, de Vries AC, Pan Q. Immunosuppressants exert differential effects on pan-coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir. United European Gastroenterol J. 2023;11(5):431-47.

  • Wang Y, Li P, Xu L, de Vries AC, Rottier RJ, Wang W, Crombag MBS, Peppelenbosch MP, Kainov DE, Pan Q. Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response. iScience. 2023;26(9):107631.

  • Weusten B, Bisschops R, Dinis-Ribeiro M, di Pietro M, Pech O, Spaander MCW, Baldaque-Silva F, Barret M, Coron E, Fernandez-Esparrach G, Fitzgerald RC, Jansen M, Jovani M, Marques-de-Sa I, Rattan A, Tan WK, Verheij EPD, Zellenrath PA, Triantafyllou K, Pouw RE. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2023;55(12):1124-46.

  • Wedemeyer H, Tergast TL, Lazarus JV, Razavi H, Bakoyannis K, Baptista-Leite R, Bartoli M, Bruggmann P, Busoi CS, Buti M, Carballo M, Castera L, Colombo M, Coutinho RS, Dadon Y, Esmat G, Esteban R, Farran JC, Gillyon-Powell M, Goldberg D, Hutchinson S, Janssen HLA, Kalamitsis G, Kondili LA, Lambert JS, Marinho RT, Maticic M, Patricello A, Peck-Radosavljevic M, Pol S, Poljak M, Pop C, Sokol T, Sypsa V, Tozun N, Younossi Z, Aghemo A, Papatheodoridis GV, Hatzakis A. Securing wider EU commitment to the elimination of hepatitis C virus. Liver Int. 2023;43(2):276-91.

  • Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M, Group R-S. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial. Lancet Gastroenterol Hepatol. 2023;8(9):790-802.

  • Zamaray B, Veld JV, Burghgraef TA, Brohet R, van Westreenen HL, van Hooft JE, Siersema PD, Tanis PJ, Consten ECJ, Dutch Snapshot Research Group DCCCI. Risk factors for a permanent stoma after resection of left-sided obstructive colon cancer - A prediction model. Eur J Surg Oncol. 2023;49(4):738-46.

Dissertations 2023

  • 24-01-2023. Laurens van Kleef. Fatty liver disease in the general population: Redefining, early detection and disease management. Supervisor: R.A. de Man. Cosupervisor: R.J. de Knegt

  • 15-03-2023. Pauline Stassen. Viral infections and complications in inflammatory bowel disease. Supervisor: M.J. Bruno. Cosupervisor: P.J. de Jonge.

  • 22-03-2023. Yingying Dou. Design of a synthetic long peptide based therapeutic vaccine strategy to treat chronic Hepatitis B. Supervisor: R.A. de Man. Cosupervisors: A.M. Woltman, S.I. Buschow

  • 24-05-2023. Renske Pauwels. Optimization of biological therapies in patients with inflammatory bowel disease: An analysis of prediction and monitoring strategies. Supervisor: C.J. van der Woude. Cosupervisors: A.C. de Vries, G. Fuhler.

  • 26-05-2023. Kasper Overbeek. Pancreatic cancer surveillance. Supervisor: M.J. Bruno. Cosupervisor: D. Cahen.

  • 31-05-2023. Rogier Goetgebuer. Viral infections and complications in inflammatory bowel disease. Supervisor: C.J. van der Woude. Cosupervisor: A.C. de Vries.

  • 10-10-2023. Judith Kwakman. Duodenoscope contamination and duodenoscope-associated infections. Supervisors: M.J. Bruno, G. Vos.

  • 11-10-2023. Jasmijn Sleutjes. Cardiovascular risk in IBD: more than a gut feeling. Supervisor: C.J. van der Woude. Cosupervisors: A.C. de Vries, J.E. Roeters van Lennep

  • 24-10-2023. Sylvia Brakenhoff. Optimising care for patients with chronic Hepatitis B and C Supervisor: R.A. de Man. Cosupervisor: R.J. de Knegt.

  • 27-10-2023. Arjan Rauwers. Bacterial Contamination of Complex Gastrointestinal Endoscopes. Supervisors: M.J. Bruno, G. Vos.

  • 19-12-2023 Noortje Hallensleben. Early detection, treatment and prevention of gallstone disease in acute pancreatitis Supervisor: M.J. Bruno

bottom of page